In-vitro blood-brain barrier models for drug screening and permeation studies: an overview S Bagchi, T Chhibber, B Lahooti, A Verma, V Borse, RD Jayant Drug design, development and therapy, 3591-3605, 2019 | 233 | 2019 |
Nanomedicine for the SARS-CoV-2: state-of-the-art and future prospects SP Varahachalam, B Lahooti, M Chamaneh, S Bagchi, T Chhibber, ... International journal of nanomedicine, 539-560, 2021 | 93 | 2021 |
CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screening T Chhibber, S Bagchi, B Lahooti, A Verma, A Al-Ahmad, MK Paul, ... Drug discovery today 25 (2), 456-465, 2020 | 58 | 2020 |
Therapeutic role of inflammasome inhibitors in neurodegenerative disorders B Lahooti, T Chhibber, S Bagchi, SP Varahachalam, RD Jayant Brain, Behavior, and Immunity 91, 771-783, 2021 | 40 | 2021 |
Targeting endothelial permeability in the EPR effect B Lahooti, RG Akwii, FT Zahra, MS Sajib, M Lamprou, A Alobaida, ... Journal of Controlled Release 361, 212-235, 2023 | 36 | 2023 |
Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application TA Al-Hilal, A Keshavarz, H Kadry, B Lahooti, A Al-Obaida, Z Ding, W Li, ... Lab on a Chip 20 (18), 3334-3345, 2020 | 32 | 2020 |
Modeling and optimization of antibacterial activity of the chitosan‐based hydrogel films using central composite design B Lahooti, M Khorram, G Karimi, A Mohammadi, A Emami Journal of biomedical materials research Part A 104 (10), 2544-2553, 2016 | 30 | 2016 |
Intelligent hydrogels in diagnostics and therapeutics A Ghosal, A Kaushik CRC Press, 2020 | 27 | 2020 |
MiRNAs as anti-angiogenic adjuvant therapy in cancer: synopsis and potential B Lahooti, S Poudel, CM Mikelis, G Mattheolabakis Frontiers in Oncology 11, 705634, 2021 | 11 | 2021 |
Hydrogels in tissue engineering T Chhibber, R Shinde, B Lahooti, S Bagchi, SP Varahachalam, A Gaddam, ... Intelligent Hydrogels in Diagnostics and Therapeutics, 105-122, 2020 | 11 | 2020 |
Endothelial-specific targeting of RhoA signaling via CD31 antibody-conjugated nanoparticles B Lahooti, RG Akwii, D Patel, S ShahbaziNia, M Lamprou, M Madadi, ... The Journal of Pharmacology and Experimental Therapeutics 385 (1), 35-49, 2023 | 6 | 2023 |
In vitro models of central nervous system barriers for blood-brain barrier permeation studies S Bagchi, B Lahooti, T Chhibber, S Varahachalam, R Mittal, A Joshi, ... Nanomedicines for Brain Drug Delivery, 235-253, 2021 | 5 | 2021 |
Chlorotoxin and lung cancer: a targeting perspective for drug delivery A Shrestha, B Lahooti, CM Mikelis, G Mattheolabakis Pharmaceutics 14 (12), 2613, 2022 | 3 | 2022 |
Drug-releasing nano-bioimplants: From basics to current progress B Joshi, J Kaur, B Lahooti, SP Varahachalam, RD Jayant, A Joshi Engineered Nanostructures for Therapeutics and Biomedical Applications, 273-295, 2023 | 1 | 2023 |
Stable Dual miR-143 and miR-506 Upregulation Inhibits Proliferation and Cell Cycle Progression A Shrestha, B Lahooti, AKMN Hossian, M Madadi, CM Mikelis, ... International journal of molecular sciences 25 (8), 4432, 2024 | | 2024 |
Impact of individual and combined deregulation of miR-143 and miR-506 on cytokinetic and morphometric parameters in A549 lung cancer cells A Shrestha, B Lahooti, M Madadi, CM Mikelis, G Mattheolabakis Cancer Research 83 (7_Supplement), 3759-3759, 2023 | | 2023 |
Endothelial‐specific nanodelivery of Rho kinase inhibitors: Targeting tumor angiogenesis and metastasis B Lahooti, R Akwii, G Mattheolabakis, CM Mikelis The FASEB Journal 36, 2022 | | 2022 |
Role of Gut–Brain Axis in HIV-1 Infection T Chhibber, B Lahooti, SP Varahachalam, S Bagchi, A Joshi, RD Jayant Gut–Brain Connection, Myth or Reality? Role of The Microbiome in Health and …, 2022 | | 2022 |
An Introduction to P-Glycoprotein, Chapter 3. P-gp Pathophysiology: Post-Translational Modification and Affecting Signaling Cascades AJRDJ Sree-Pooja Varahachalam, Jaspreet Kaur, Minitha Jacob, Behnaz Lahooti ... https://novapublishers.com/shop/an-introduction-to-p-glycoprotein 1, 1-390, 2021 | | 2021 |